Enrique M Toledo - Publications

Affiliations: 
2010-2017 MBB Karolinska Institute, Stockholm, Sweden 

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ahmed M, Owens MJS, Toledo EM, Arenas E, Bradley M, Ffrench-Constant C. Combinatorial ECM Arrays Identify Cooperative Roles for Matricellular Proteins in Enhancing the Generation of TH+ Neurons From Human Pluripotent Cells. Frontiers in Cell and Developmental Biology. 9: 755406. PMID 34926447 DOI: 10.3389/fcell.2021.755406  0.688
2020 Toledo EM, Yang S, Gyllborg D, van Wijk KE, Sinha I, Varas-Godoy M, Grigsby CL, Lönnerberg P, Islam S, Steffensen KR, Linnarsson S, Arenas E. Srebf1 Controls Midbrain Dopaminergic Neurogenesis. Cell Reports. 31: 107601. PMID 32375051 DOI: 10.1016/J.Celrep.2020.107601  0.762
2018 Yang S, Toledo EM, Rosmaninho P, Peng C, Uhlén P, Castro DS, Arenas E. A Zeb2-miR-200c loop controls midbrain dopaminergic neuron neurogenesis and migration. Communications Biology. 1: 75. PMID 30271956 DOI: 10.1038/s42003-018-0080-0  0.814
2018 Gyllborg D, Ahmed M, Toledo EM, Theofilopoulos S, Yang S, Ffrench-Constant C, Arenas E. The Matricellular Protein R-Spondin 2 Promotes Midbrain Dopaminergic Neurogenesis and Differentiation. Stem Cell Reports. PMID 30146491 DOI: 10.1016/J.Stemcr.2018.07.014  0.767
2018 Okawa S, Saltó C, Ravichandran S, Yang S, Toledo EM, Arenas E, Del Sol A. Transcriptional synergy as an emergent property defining cell subpopulation identity enables population shift. Nature Communications. 9: 2595. PMID 29968757 DOI: 10.1038/S41467-018-05016-8  0.802
2017 Zhang D, Yang S, Toledo EM, Gyllborg D, Saltó C, Carlos Villaescusa J, Arenas E. Niche-derived laminin-511 promotes midbrain dopaminergic neuron survival and differentiation through YAP. Science Signaling. 10. PMID 28831020 DOI: 10.1126/Scisignal.Aal4165  0.791
2017 Kitambi SS, Toledo EM, Usoskin D, Wee S, Harisankar A, Svensson R, Sigmundsson K, Kalderén C, Niklasson M, Kundu S, Aranda S, Westermark B, Uhrbom L, Andäng M, Damberg P, et al. Retraction Notice to: Vulnerability of Glioblastoma Cells to Catastrophic Vacuolization and Death Induced by a Small Molecule. Cell. 170: 407. PMID 28709005 DOI: 10.1016/j.cell.2017.06.044  0.477
2017 Toledo EM, Gyllborg D, Arenas E. Translation of WNT developmental programs into stem cell replacement strategies for the treatment of Parkinson's disease. British Journal of Pharmacology. PMID 28547771 DOI: 10.1111/Bph.13871  0.82
2017 Hörtenhuber M, Toledo EM, Smedler E, Arenas E, Malmersjö S, Louhivuori L, Uhlén P. Mapping Genes for Calcium Signaling and Their Associated Human Genetic Disorders. Bioinformatics (Oxford, England). PMID 28430858 DOI: 10.1093/Bioinformatics/Btx225  0.533
2017 di Val Cervo PR, Romanov RA, Spigolon G, Masini D, Martín-Montañez E, Toledo EM, La Manno G, Feyder M, Pifl C, Ng YH, Sánchez SP, Linnarsson S, Wernig M, Harkany T, Fisone G, et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nature Biotechnology. PMID 28398344 DOI: 10.1038/Nbt.3835  0.689
2016 La Manno G, Gyllborg D, Codeluppi S, Nishimura K, Salto C, Zeisel A, Borm LE, Stott SR, Toledo EM, Villaescusa JC, Lönnerberg P, Ryge J, Barker RA, Arenas E, Linnarsson S. Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells. Cell. 167: 566-580.e19. PMID 27716510 DOI: 10.1016/J.Cell.2016.09.027  0.8
2016 Villaescusa JC, Li B, Toledo EM, Rivetti di Val Cervo P, Yang S, Stott SR, Kaiser K, Islam S, Gyllborg D, Laguna-Goya R, Landreh M, Lönnerberg P, Falk A, Bergman T, Barker RA, et al. A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease. The Embo Journal. PMID 27354364 DOI: 10.15252/Embj.201593725  0.763
2015 Bravo-Zehnder M, Toledo EM, Segovia-Miranda F, Serrano FG, Benito MJ, Metz C, Retamal C, Álvarez A, Massardo L, Inestrosa NC, González A. Anti-ribosomal P protein autoantibodies from patients with neuropsychiatric lupus impair memory in mice. Arthritis & Rheumatology (Hoboken, N.J.). 67: 204-14. PMID 25302407 DOI: 10.1002/Art.38900  0.326
2014 Kitambi SS, Toledo EM, Usoskin D, Wee S, Harisankar A, Svensson R, Sigmundsson K, Kalderén C, Niklasson M, Kundu S, Aranda S, Westermark B, Uhrbom L, Andäng M, Damberg P, et al. Vulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small molecule. Cell. 157: 313-28. PMID 24656405 DOI: 10.1016/J.Cell.2014.02.021  0.572
2013 Theofilopoulos S, Wang Y, Kitambi SS, Sacchetti P, Sousa KM, Bodin K, Kirk J, Saltó C, Gustafsson M, Toledo EM, Karu K, Gustafsson JÃ…, Steffensen KR, Ernfors P, Sjövall J, et al. Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis. Nature Chemical Biology. 9: 126-33. PMID 23292650 DOI: 10.1038/Nchembio.1156  0.778
2012 Kele J, Andersson ER, Villaescusa JC, Cajanek L, Parish CL, Bonilla S, Toledo EM, Bryja V, Rubin JS, Shimono A, Arenas E. SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells. Stem Cells (Dayton, Ohio). 30: 865-75. PMID 22290867 DOI: 10.1002/Stem.1049  0.73
2010 Toledo EM, Inestrosa NC. Wnt signaling activation reduces neuropathological markers in a mouse model of Alzheimer's disease Molecular Psychiatry. 15: 228. DOI: 10.1038/Mp.2010.9  0.329
2009 Cerpa W, Toledo EM, Varela-Nallar L, Inestrosa NC. The role of Wnt signaling in neuroprotection. Drug News & Perspectives. 22: 579-91. PMID 20140278 DOI: 10.1358/Dnp.2009.22.10.1443391  0.376
2009 Arrázola MS, Varela-Nallar L, Colombres M, Toledo EM, Cruzat F, Pavez L, Assar R, Aravena A, González M, Montecino M, Maass A, Martínez S, Inestrosa NC. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. Journal of Cellular Physiology. 221: 658-67. PMID 19711354 DOI: 10.1002/Jcp.21902  0.442
2008 Toledo EM, Colombres M, Inestrosa NC. Wnt signaling in neuroprotection and stem cell differentiation. Progress in Neurobiology. 86: 281-96. PMID 18786602 DOI: 10.1016/J.Pneurobio.2008.08.001  0.455
2008 Inestrosa NC, Toledo EM. The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease. Molecular Neurodegeneration. 3: 9. PMID 18652670 DOI: 10.1186/1750-1326-3-9  0.336
2008 Cancino GI, Toledo EM, Leal NR, Hernandez DE, Yévenes LF, Inestrosa NC, Alvarez AR. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. Brain : a Journal of Neurology. 131: 2425-42. PMID 18559370 DOI: 10.1093/Brain/Awn125  0.316
2007 Farías GG, Vallés AS, Colombres M, Godoy JA, Toledo EM, Lukas RJ, Barrantes FJ, Inestrosa NC. Wnt-7a induces presynaptic colocalization of alpha 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 5313-25. PMID 17507554 DOI: 10.1523/Jneurosci.3934-06.2007  0.304
2006 Varela-Nallar L, Toledo EM, Chacón MA, Inestrosa NC. The functional links between prion protein and copper. Biological Research. 39: 39-44. PMID 16629163 DOI: 10.4067/S0716-97602006000100005  0.306
2006 Varela-Nallar L, Toledo EM, Larrondo LF, Cabral ALB, Martins VR, Inestrosa NC. Induction of cellular prion protein gene expression by copper in neurons American Journal of Physiology - Cell Physiology. 290: C271-C281. PMID 16148034 DOI: 10.1152/Ajpcell.00160.2005  0.474
Show low-probability matches.